Australia's Proteomics International jumps on new stress test for marathon runners
** Proteomics International Laboratories PIQ.AX jumps as
much as 9.5% to A$0.810, highest since Oct. 11
** Medical technology firm says its OxiDx test - a
finger-prick blood test to measure oxidative stress - accurately
identifies muscle damage in marathon runners
** PIQ sets sights on H1 CY25 for Australian commercial
launch of OxiDx test
** More than 540,000 shares traded, 5x the 30-day avg
** Stock trims YTD losses to 12.3%
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com;))
Recent news on Proteomics International Laboratories
See all newsBrief: Proteomics International Laboratories Launches Share Purchase Plan To Raise Up To A$5 MLN
Australia's Proteomics slips to four-month low on discounted share sale plan
Brief: Proteomics International Laboratories Posts FY Loss Attributable A$8.6 Million
Brief: Proteomics International Laboratories Signs Agreement With Healius For Promarker Portfolio
Australia's Proteomics International soars on distribution deal with Healius